The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria
ABSTRACT Members of the genus Mycobacterium are the most prevalent cause of infectious diseases. Mycobacteria have a complex cell envelope containing a peptidoglycan layer and an additional arabinogalactan polymer to which a mycolic acid bilayer is linked; this complex, multilayered cell wall compos...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/20eaefdb682943f8a062af6d59aa6b64 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:20eaefdb682943f8a062af6d59aa6b64 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:20eaefdb682943f8a062af6d59aa6b642021-11-15T15:51:07ZThe Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria10.1128/mBio.02213-162150-7511https://doaj.org/article/20eaefdb682943f8a062af6d59aa6b642017-03-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.02213-16https://doaj.org/toc/2150-7511ABSTRACT Members of the genus Mycobacterium are the most prevalent cause of infectious diseases. Mycobacteria have a complex cell envelope containing a peptidoglycan layer and an additional arabinogalactan polymer to which a mycolic acid bilayer is linked; this complex, multilayered cell wall composition (mAGP) is conserved among all CMN group bacteria. The arabinogalactan and mycolic acid synthesis pathways constitute effective drug targets for tuberculosis treatment. Ethambutol (EMB), a classical antituberculosis drug, inhibits the synthesis of the arabinose polymer. Although EMB acts bacteriostatically, its underlying molecular mechanism remains unclear. Here, we used Corynebacterium glutamicum and Mycobacterium phlei as model organisms to study the effects of EMB at the single-cell level. Our results demonstrate that EMB specifically blocks apical cell wall synthesis, but not cell division, explaining the bacteriostatic effect of EMB. Furthermore, the data suggest that members of the family Corynebacterineae have two dedicated machineries for cell elongation (elongasome) and cytokinesis (divisome). IMPORTANCE Antibiotic treatment of bacterial pathogens has contributed enormously to the increase in human health. Despite the apparent importance of antibiotic treatment of bacterial infections, surprisingly little is known about the molecular functions of antibiotic actions in the bacterial cell. Here, we analyzed the molecular effects of ethambutol, a first-line antibiotic against infections caused by members of the genus Mycobacterium. We find that this drug selectively blocks apical cell growth but still allows for effective cytokinesis. As a consequence, cells survive ethambutol treatment and adopt a pneumococcal cell growth mode with cell wall synthesis only at the site of cell division. However, combined treatment of ethambutol and beta-lactam antibiotics acts synergistically and effectively stops cell proliferation.Karin SchubertBoris SiegerFabian MeyerGiacomo GiacomelliKati BöhmAngela RieblingerLaura LindenthalNadja SachsGerhard WannerMarc BramkampAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 8, Iss 1 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Microbiology QR1-502 |
spellingShingle |
Microbiology QR1-502 Karin Schubert Boris Sieger Fabian Meyer Giacomo Giacomelli Kati Böhm Angela Rieblinger Laura Lindenthal Nadja Sachs Gerhard Wanner Marc Bramkamp The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria |
description |
ABSTRACT Members of the genus Mycobacterium are the most prevalent cause of infectious diseases. Mycobacteria have a complex cell envelope containing a peptidoglycan layer and an additional arabinogalactan polymer to which a mycolic acid bilayer is linked; this complex, multilayered cell wall composition (mAGP) is conserved among all CMN group bacteria. The arabinogalactan and mycolic acid synthesis pathways constitute effective drug targets for tuberculosis treatment. Ethambutol (EMB), a classical antituberculosis drug, inhibits the synthesis of the arabinose polymer. Although EMB acts bacteriostatically, its underlying molecular mechanism remains unclear. Here, we used Corynebacterium glutamicum and Mycobacterium phlei as model organisms to study the effects of EMB at the single-cell level. Our results demonstrate that EMB specifically blocks apical cell wall synthesis, but not cell division, explaining the bacteriostatic effect of EMB. Furthermore, the data suggest that members of the family Corynebacterineae have two dedicated machineries for cell elongation (elongasome) and cytokinesis (divisome). IMPORTANCE Antibiotic treatment of bacterial pathogens has contributed enormously to the increase in human health. Despite the apparent importance of antibiotic treatment of bacterial infections, surprisingly little is known about the molecular functions of antibiotic actions in the bacterial cell. Here, we analyzed the molecular effects of ethambutol, a first-line antibiotic against infections caused by members of the genus Mycobacterium. We find that this drug selectively blocks apical cell growth but still allows for effective cytokinesis. As a consequence, cells survive ethambutol treatment and adopt a pneumococcal cell growth mode with cell wall synthesis only at the site of cell division. However, combined treatment of ethambutol and beta-lactam antibiotics acts synergistically and effectively stops cell proliferation. |
format |
article |
author |
Karin Schubert Boris Sieger Fabian Meyer Giacomo Giacomelli Kati Böhm Angela Rieblinger Laura Lindenthal Nadja Sachs Gerhard Wanner Marc Bramkamp |
author_facet |
Karin Schubert Boris Sieger Fabian Meyer Giacomo Giacomelli Kati Böhm Angela Rieblinger Laura Lindenthal Nadja Sachs Gerhard Wanner Marc Bramkamp |
author_sort |
Karin Schubert |
title |
The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria |
title_short |
The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria |
title_full |
The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria |
title_fullStr |
The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria |
title_full_unstemmed |
The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria |
title_sort |
antituberculosis drug ethambutol selectively blocks apical growth in cmn group bacteria |
publisher |
American Society for Microbiology |
publishDate |
2017 |
url |
https://doaj.org/article/20eaefdb682943f8a062af6d59aa6b64 |
work_keys_str_mv |
AT karinschubert theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT borissieger theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT fabianmeyer theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT giacomogiacomelli theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT katibohm theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT angelarieblinger theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT lauralindenthal theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT nadjasachs theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT gerhardwanner theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT marcbramkamp theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT karinschubert antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT borissieger antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT fabianmeyer antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT giacomogiacomelli antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT katibohm antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT angelarieblinger antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT lauralindenthal antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT nadjasachs antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT gerhardwanner antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria AT marcbramkamp antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria |
_version_ |
1718427386104512512 |